Clinical Trial Detail

NCT ID NCT01783587
Title Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

laryngeal squamous cell carcinoma

hypopharynx cancer

oral squamous cell carcinoma

head and neck squamous cell carcinoma

oropharynx cancer

Therapies

Afatinib

Docetaxel

Age Groups: adult

No variant requirements are available.